UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000010639
Receipt number R000012444
Scientific Title Phase I study of TS-1+irinotecan+cetuximab as the first-line therapy in patients with KRAS wild-type metastatic colorectal cancer
Date of disclosure of the study information 2013/05/07
Last modified on 2019/03/08 09:58:11

No. Disposal Last modified on Item of update
1 Insert 2013/05/03 08:27:35
2 Update 2013/11/03 09:34:01 TEL
Email
3 Update 2014/05/03 11:28:50 Recruitment status
4 Update 2016/05/03 09:37:52 Name of primary person or sponsor
Organization
5 Update 2016/11/15 13:26:29 Key inclusion criteria
6 Update 2016/11/15 13:27:45 Publication of results
7 Update 2019/03/08 09:58:11 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded